Skip to main content
. 2021 May 28;12:582447. doi: 10.3389/fphar.2021.582447

FIGURE 5.

FIGURE 5

The analysis of overall survival rate. The result showed no difference in one- and two-year OS rate between the two groups (OR = 1.41, 95% CI [0.86 to 2.30], p = 0.17; and OR = 2.54, 95% CI [1.00 to 6.42], p = 0.05). Note: GP, Gemcitabine and cisplatin.